We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.

Brain Tumor Center

Subscribe to Brain Tumor Center

You are here

Neuropsychologist and Cognitive Remediation Specialist Amanda Sacks, Ph.D., Joins the Faculty

Dr. Amanda Sacks

Dr. Philip E. Stieg, Chairman of the Weill Cornell Brain and Spine Center and Neurosurgeon-in-Chief of New York-Presbyterian/Weill Cornell Medical Center, has announced that Amanda L. Sacks, Ph.D., ABPP-CN, has been appointed to the faculty of Weill Cornell Medical College. Dr. Sacks is a neuropsychologist who specializes in cognitive remediation for deficits caused by traumatic brain injury; brain tumors and cranial surgery; chemotherapy and radiation; and stroke and other cerebrovascular conditions and events.

Moving Towards a Cure

Dr. Jeffrey Greenfield and Dr. Mark Souweidane present the Rainbow Award to Denise and Courtney Downing

On Saturday, July 27, hundreds of runners and walkers hit the trail for the second annual Miles for Hope “Moving Towards a Cure” race/walk, which benefits the Weill Cornell Pediatric Brain and Spine Center’s research into rare and inoperable brain tumors of childhood and adolescents.

NewYork-Presbyterian Hospital Ranked Number 1 in New York – Again

NewYork-Presbyterian Hospital Ranked Number 1 in New York – Again

The hospital was once again included on U.S. News' prestigious Honor Roll, a designation given to only 18 hospitals nationwide.

New York’s Best Neurosurgeons

The Weill Cornell Brain and Spine Center is proud to have three of our neurosurgeons included on this year’s list of Best Doctors in New York, as published in this week’s issue of New York magazine.

Weill Cornell Brain and Spine Center Welcomes Three Incoming Residents

The post-graduate year 1 residents (PGY-1’s) arrive this month to embark on an intensive seven-year training program to become neurological surgeons and neuroscience researchers, studying under some of the top brain and spine surgeons and researchers in the world today.

Dr. Boockvar Awarded $100,000 by Voices Against Brain Cancer

Mario Lichtenstein of Voices Against Brain Cancer Awards $100,000 to John Boockvar, MD

John Boockvar, M.D., was awarded $100,000 by Voices Against Brain Cancer at last night's 8th Annual Sounding Off for a Cure NY Benefit. The award, which covers the period from July 1, 2013 through June 30, 2014, is to support Dr. Boockvar's work investigating “Intra-arterial delivery to the glioma stem cell niche.”

5 Weill Cornell Neurosurgeons Named to List of 2013 SuperDoctors

This year’s list includes Neurosurgeon-in-Chief Philip Stieg, M.D., Ph.D.; Vice Chairman and Director of Pediatric Neurosurgery Mark Souweidane, M.D.; Vice Chairman for Research and Director of Movement Disorders Michael Kaplitt, M.D., Ph.D.; Chief of Spinal Surgery Roger Hartl, M.D.; and spine surgeon Eric Elowitz, M.D.

Dr. Schwartz Joins Editorial Board of Journal of Neurosurgery

Theodore Schwartz, M.D., has been named to the editorial board of the Journal of Neurosurgery, the official publication of the American Association of Neurosurgeons (AANS) and considered the leading scholarly journal on neurosurgery in the world.

Maria Bartiromo to Deliver Featured Keynote Address at Brain Tumor Biotech Summit 2013

CNBC anchor Maria Bartiromo will deliver the featured keynote address at Brain Tumor Biotech Summit 2013, speaking on “Innovation in the Changing World Economy.” Bartiromo, who anchors CNBC's "Closing Bell with Maria Bartiromo” as well as the nationally syndicated "On the Money with Maria Bartiromo," is an award-winning business journalist and author.

Orthotopic glioblastoma stem-like cell xenograft model in mice to evaluate intra-arterial delivery of bevacizumab: from bedside to bench

Bevacizumab (BV), a humanized monocolonal antibody directed against vascular endothelial growth factor (VEGF), is a standard intravenous (IV) treatment for recurrent glioblastoma multiforme (GBM),

Dr. Theodore Schwartz and Dr. Gabriella Wernicke Present Clinical Findings on Cesium-131 Study

The presentation was made at the annual Scientific Meeting of the Society for Neuro-Oncology (SNO) in Washington, DC. Their study compares the relative effectiveness of Cesium-131 versus other common therapies in treating newly diagnosed metastatic brain tumors.

Dr. Boockvar and Patrick Kennedy Appear on CNBC to Talk About Brain Cancer Research Funding

Dr. John Boockvar, former Representative Patrick Kennedy, and biotechnology financial analyst Franklin Berger talk about the state of cancer funding, particularly funding for brain cancer research, on the CNBC show Squawk Box. Watch the video:

Fourth-Year Resident Heather H. McCrea, MD, PhD, Awarded 2012-2013 NREF Research Grant

Dr. McCrea's study is titled "The Role of Angiocrine Expression of Notch Ligands in Glioma Progression."

6 Weill Cornell Neurosurgeons Named 2012 Top Doctors

Six neurosurgeons from the Weill Cornell Brain and Spine Center have been named to the Castle Connolly list of Top Doctors for the New York metro area.

Dr. Boockvar Appears on The Dr. Oz Show

Dr. Boockvar on The Dr. Oz Show

Dr. John Boockvar made two appearances on The Dr. Oz Show to discuss brain tumors and their risk factors. Watch the videos.

Six Weill Cornell Neurosurgeons Named as U.S. News Top Doctors

We're proud to have six of our neurosurgeons on this first edition of the magazine's list of top doctors.

Dr. Theodore H. Schwartz and Dr. A. Gabriella Wernicke Achieve Breakthrough Use of Cesium-131 for Intracavitary Brachytherapy in Malignant Brain Tumor

Intracavitary brachytherapy is a minimally invasive technique used to line a surgical cavity with radioactive seeds — cancer-fighting radioisotopes encased in capsules the size of a rice grain — after removal of malignant disease. This procedure delivers high-dose radiation to the tumor cavity margin to prevent recurrence of microscopic disease in patients with malignant brain tumors.

Novel Superselective Intraaterial Cerebral Approach Using Avastin Yields Successful Results

Two neurosurgeons at the Weill Cornell Brain and Spine Center are pioneering an exciting new approach for the treatment of recurrent malignant brain tumors. As reported in this New York Times article published on November 17, 2009, their novel approach to treating these resistant brain tumors is yielding successful results. Follow-up MRI imaging on the treated patients has shown that their tumors have shown a dramatic response to the treatment.

Dr. Boockvar Appears on CNBC 'Squawk Box' to Talk About Avastin Trial

Dr. John Boockvar appeared on the CNBC show Squawk Box to talk about his new clinical trial of Avastin for glioblastoma multiforme (GBM). Watch the video:


Subscribe to Brain Tumor Center